Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: a question of mechanism.
Stein
C A
CA
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002460:Cell Line; D016259:Genes, myc; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology; D016376:Oligonucleotides, Antisense / Q000494:pharmacology* / Q000627:therapeutic use; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis; D011519:Proto-Oncogenes; D013873:Thionucleotides; D013926:Thrombopoietin / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D006133:Growth Substances; D016376:Oligonucleotides, Antisense; D016271:Proto-Oncogene Proteins c-myc; D013873:Thionucleotides; D013926:Thrombopoietin